As of 2025-12-13, the Relative Valuation of Arena Pharmaceuticals Inc (ARNA) is (149.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 99.99 USD, the upside of Arena Pharmaceuticals Inc based on Relative Valuation is -249.5%.
The range of the Relative Valuation is (132.96) - (169.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 17.0x | 14.6x |
| Forward P/E multiples | 13.3x - 17.2x | 15.2x |
| Fair Price | (132.96) - (169.95) | (149.46) |
| Upside | -233.0% - -270.0% | -249.5% |
| Date | P/E |